Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity
Journal of the National Comprehensive Cancer Network · 2026-07 · 24 (7)
DOI: 10.6004/jnccn.2026.7015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-07. Verfasst von Mallik Greene und 10 weiteren Autor:innen. Beteiligte Einrichtung: 1Abbott, Madison, WI. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, DNA, Early Detection of Cancer. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Fecal immunochemical tests (FITs), fecal occult blood tests (FOBTs), and multitarget stool DNA (mt-sDNA) tests are convenient, noninvasive colorectal cancer (CRC) screening strategies. However, delays in or failure to complete follow-up colonoscopy (FU-CY) after a positive noninvasive test are associated with higher CRC incidence, complications, and mortality. We sought to evaluate FU-CY rates, time to colonoscopy, and compliance predictors. Patients and Methods: This retrospective cohort study linked 2 data sources: Komodo Health Data with Exact Sciences Laboratories. Data were collected from January 2016 to June 2023 and analyzed in 2024. Study participants (ages 45–75 years) were individuals with positive stool-based CRC screening tests (FIT, guaiac-based FOBT, or mt-sDNA tests). FU-CY compliance was assessed at 30-day intervals up to 365 days, and logistic regression was used to identify predictors of FU-CY.
Results
Among 362,646 participants, colonoscopy compliance was 77.1% for mt-sDNA and 45.1% for FIT/FOBT ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1Abbott, Madison, WI.
- 2Geisel School of Medicine at Dartmouth, Hanover, NH.
- 3Kansas University Medical Center, Kansas City, KS.
- 4Department of Medicine, Duke University, Durham, NC.
- 5Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
- 6AltaMed, Los Angeles, CA.
Zitieren
APA
Greene, M., Stieber, B., Ozbay, A. B., Anderson, J., LeMaster, J., Dore, M., Stukalin, I., Arroyo, J., Ebner, D. W., Fendrick, A. M., & Karlitz, J. J. (2026). Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity. Journal of the National Comprehensive Cancer Network, 24(7). https://doi.org/10.6004/jnccn.2026.7015
Vancouver
Greene M, Stieber B, Ozbay AB, Anderson J, LeMaster J, Dore M, et al. Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity. Journal of the National Comprehensive Cancer Network. 2026;24(7). doi:10.6004/jnccn.2026.7015
BibTeX
@article{Greene2026,
author = {Greene, Mallik and Stieber, Brad and Ozbay, A Burak and Anderson, Joseph and LeMaster, Joseph and Dore, Michael and Stukalin, Igor and Arroyo, Jeffrey and Ebner, Derek W and Fendrick, A Mark and Karlitz, Jordan J},
title = {Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {7},
doi = {10.6004/jnccn.2026.7015}
}
EUVIMED